Octa-Cationic Porphyrin-Functionalized Biocompatible Nanocomposite: A Promising Candidate for Enhanced Combinatorial Photodynamic and Photothermal Tumor Therapy.
{"title":"Octa-Cationic Porphyrin-Functionalized Biocompatible Nanocomposite: A Promising Candidate for Enhanced Combinatorial Photodynamic and Photothermal Tumor Therapy.","authors":"Chang-Hao Jiang, Yong-Hui Li, Yue Yuan, Chen-Yu Wang, Jun-Qing Chu, Gui-Mei Han, De-Ming Kong, Qi-Liang Cai, Li-Na Zhu","doi":"10.1021/acs.jmedchem.4c02584","DOIUrl":null,"url":null,"abstract":"<p><p>The integration of photodynamic therapy (PDT) and photothermal therapy (PTT) offers a promising strategy for enhancing phototherapy efficiency. Herein, we present a dual-functional, biocompatible nanocomposite system for combination PDT/PTT therapy. The system utilizes a highly biocompatible nanoparticle assembled by an amphiphilic short peptide with the assistance of Zn<sup>2+</sup> as a carrier. The photothermal convertor is loaded within the nanoparticle, while a cationic porphyrin photosensitizer is assembled on the surface. The water-soluble cationic porphyrin (M<sub>8</sub>PzEOPP), designed with eight positive charges, provides a strong electrostatic interaction for stable assembly on the nanocomposite surface. This location-independent assembly effectively maintains the optical characteristics of both the photosensitizer and the photothermal convertor, endowing the nanocomposite with effective photodynamic and photothermal properties. The nanocomposite exhibits excellent tumor-targeting accumulation behavior, low dark toxicity, robust extracellular biostability, and high cell internalization efficiency. Its enhanced performance in combinatorial therapy is demonstrated through both in vitro and in vivo experiments.</p>","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":" ","pages":"3409-3419"},"PeriodicalIF":6.8000,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.jmedchem.4c02584","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/26 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
The integration of photodynamic therapy (PDT) and photothermal therapy (PTT) offers a promising strategy for enhancing phototherapy efficiency. Herein, we present a dual-functional, biocompatible nanocomposite system for combination PDT/PTT therapy. The system utilizes a highly biocompatible nanoparticle assembled by an amphiphilic short peptide with the assistance of Zn2+ as a carrier. The photothermal convertor is loaded within the nanoparticle, while a cationic porphyrin photosensitizer is assembled on the surface. The water-soluble cationic porphyrin (M8PzEOPP), designed with eight positive charges, provides a strong electrostatic interaction for stable assembly on the nanocomposite surface. This location-independent assembly effectively maintains the optical characteristics of both the photosensitizer and the photothermal convertor, endowing the nanocomposite with effective photodynamic and photothermal properties. The nanocomposite exhibits excellent tumor-targeting accumulation behavior, low dark toxicity, robust extracellular biostability, and high cell internalization efficiency. Its enhanced performance in combinatorial therapy is demonstrated through both in vitro and in vivo experiments.
期刊介绍:
The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents.
The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.